-+ 0.00%
-+ 0.00%
-+ 0.00%

Phoenix Nest Awarded Prestigious Small Business Innovation Research (SBIR) Grant of $2,984,658

Barchart·08/05/2026 13:45:00
Listen to the news

Much Needed Funding Supports Gene Therapy Manufacturing for Children with Sanfilippo Syndrome Type C

BROOKLYN, N.Y., Aug. 5, 2026 /PRNewswire/ -- Phoenix Nest is a thrilled recipient of the Small Business Innovation Research (SBIR) grant [R44NS147802; $2,984,658] that will fund manufacturing of clinical grade product to treat Sanfilippo syndrome type C or Mucopolysaccharidosis type III (MPS III) patients. This AAV9 gene therapy, JLK-247, would be the first treatment and a potential cure for this rare and fatal childhood disease.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.